› added 7 months ago
67
TIL Japan during the 60s and into the late 80s was using a coagulant catalyst to treat hemophilia called Fibrinogen Concentrate by pooling plasma from donors. However, due to under-regulation, donors were not screened for diseases like Hepatitis, which resulted in thousands infected